Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp

被引:0
作者
Ran Zhao
Wenjun Qin
Ruihuan Qin
Jing Han
Can Li
Yisheng Wang
Congjian Xu
机构
[1] Fudan University,Institute of Biomedical Sciences
[2] Fudan University,Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[3] Obstetrics and Gynecology Hospital of Fudan University,Department of Obstetrics and Gynecology of Shanghai Medical School
[4] Fudan University,undefined
[5] Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases,undefined
来源
Clinical Proteomics | 2017年 / 14卷
关键词
Ovarian cancer; Drug resistance; Glycomics; Gene expression analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[31]   Study on the Intervention Mechanism of Cryptotanshinone on Human A2780 Ovarian Cancer Cell Line Using GC-MS-Based Cellular Metabolomics [J].
Wang, Tong ;
Yin, Shusheng ;
Gu, Juan ;
Li, Jingjing ;
Zhang, Mengmeng ;
Shan, Jinjun ;
Wu, Xiao ;
Li, Yongming .
PHARMACEUTICALS, 2023, 16 (06)
[32]   Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways [J].
Yan, Hong ;
Che, Xiaoxia ;
Lv, Qingtao ;
Zhang, Lili ;
Dongol, Samina ;
Wang, Yilin ;
Sun, Hengzi ;
Jiang, Jie .
ONCOLOGY LETTERS, 2017, 13 (06) :4806-4812
[34]   Short hairpin RNA-mediated MDR1 gene silencing increases apoptosis of human ovarian cancer cell line A2780/taxol [J].
Xu, Hui ;
Hong, Fan-zhen ;
Li, Su ;
Zhang, Ping ;
Zhu, Lin .
CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (02) :138-142
[35]   ABT-737 increases cisplatin sensitivity through the ROS-ASK1-JNK MAPK signaling axis in human ovarian cancer cisplatin-resistant A2780/DDP cells [J].
Li, Xiaoning ;
Guo, Yumeng ;
Xing, Zihan ;
Gong, Tao ;
Yang, Lijun ;
Yang, Tao ;
Chang, Bingmei ;
Wang, Xiaoxia ;
Yu, Baofeng ;
Guo, Rui .
ONCOLOGY REPORTS, 2024, 52 (03)
[36]   Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line [J].
Golbashirzadeh, Morteza ;
Heidari, Hamid Reza ;
Talebi, Mehdi ;
Khosroushahi, Ahmad Yari .
ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (01) :176-187
[37]   Theaflavin-3, 3′-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells [J].
Tu, Youying ;
Kim, Eunhye ;
Gao, Ying ;
Rankin, Gary O. ;
Li, Bo ;
Chen, Yi Charlie .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (06) :2657-2665
[38]   Multi-drug-resistance efflux in cisplatin-naive and cisplatin-exposed A2780 ovarian cancer cells responds differently to cell culture dimensionality [J].
Koshkin, Vasilij ;
De Oliveira, Mariana Bleker ;
Peng, Chun ;
Ailles, Laurie E. ;
Liu, Geoffrey ;
Covens, Allan ;
Krylov, Sergey N. .
MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (02)
[39]   Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways [J].
Liu, Hai-Zhong ;
Yu, Chao ;
Yang, Zhu ;
He, Jun-Lin ;
Chen, Wen-Juan ;
Yin, Juan ;
Li, Wen-Ming ;
Liu, Hong-Tao ;
Wang, Ying-Xiong .
MOLECULAR MEDICINE REPORTS, 2011, 4 (05) :985-992
[40]   Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1 [J].
Ma, JG ;
Maliepaard, M ;
Kolker, HJ ;
Verweij, J ;
Schellens, JHM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (03) :186-192